BNET Industries

Market Cap:$119.9M
Last Fiscal Year Sales:$99.5M
  • Public
Dow Jones Description

China is the epitome of "risky business". Numerous Fortune 100 companies have failed disastrously in China, and the "balance sheet" since the post-Tiananmen Square massacre is surfeit with (appropriately) red ink. So why and how will Genesis succeed? The odds for success are long and discouraging. Yet, we believe that we can mitigate against some of the risks by having created a revitalized business network, by late 2005, that might deliver handsome rewards. No fellow adventurer should join us, however, unless, in addition to the daunting challenges, a true commitment to patience and dedication is at the very forefront. Success in China takes years, if ever it is to be realized. In addition to experienced management in Beijing and the US, Genesis has developed important professional ties in both hemispheres. As the "Year of the Golden Pig" celebration approached on February 18, 2007, Genesis China engaged a media company to research the Company and provide a comprehensive, updated Profile. Although compensated by Genesis, the researcher did furnish an abundance of useful information that could assist interested parties in formulating informed, objective opinions about the Company. In August 2006, Genesis China formally joined the United States Chamber of Commerce, headquartered near the White House in Washington D.C. As an active member amongst its 3 million participating companies and organizations, Genesis China believes that this USCC membership could significantly add...

Chairman and Chief Executive Officer
Wubo Cao
Number of Employees 440
Contact Information

Middle Section Longmao Street Area A Laiyang

Yantai 265200

www.jiangbophar...

(86) 535 7282997

NAICS Code Pharmaceutical Preparation Manufacturing: 325412

Recent Events

  • Jiangbo Pharmaceuticals Announces First Quarter Fiscal Year 2010 Results

    11/17/09 - Financial Announcement - View Story

  • Jiangbo Pharmaceuticals Announces Resignation of Chief Operating Officer

    10/22/09 - Mgmt. Change Leaving - Other - View Story

  • Jiangbo Pharmaceuticals Announces Record Fourth Quarter and Fiscal Year 2009 Results

    9/29/09 - Merger / Acquisition - View Story

  • Jiangbo Pharmaceuticals Guides Below Estimates

    9/29/09 - Financial Announcement - View Story

News & Analysis

genesis pharmaceuticals enterprises inc. - All News and Analysis

Decision Makers

Name (plus bio) Position
Adam Wasserman Chief Financial Officer
Haibo Xu Coo
Sung Elsa Cfo
Jingsheng Xin Vice President&Director of Equipment
Lining Dong Vice President&Director of Technology
Weidong Yang Vice President&Director of Sales
Xin Jingsheng Vice President & Director, Equipment
Robert Cain Outside Director
Rodrigo Arboleda Outside Director
Hong Xue Financial Controller
Kenneth Clinton Director
Li Shaoqing Director
Robert Zhuang Director

Board of Directors

Name (plus bio) Position
Wubo Cao Chairman and Chief Executive Officer
John Yang Wang Board of Directors
Michael Marks Board of Directors
Xiaowei Feng Board of Directors

Organization Position Status
JIANGBO PHARMACEUTICALS, INC. Chairman and Chief Executive Officer Current

Organization Position Status
JIANGBO PHARMACEUTICALS, INC. Chief Financial Officer Current

Organization Position Status
JIANGBO PHARMACEUTICALS, INC. Coo Current

Organization Position Status
JIANGBO PHARMACEUTICALS, INC. Cfo Current
American Institute of Certified Public Accountants Board of Directors Current
CFO Oncall, Inc. Vice President Former
Applica Consumer Products, Inc. Senior Internal Auditor Former
Sherb & Co., Llp Former

Organization Position Status
JIANGBO PHARMACEUTICALS, INC. Vice President&Director of Equipment Current

Organization Position Status
JIANGBO PHARMACEUTICALS, INC. Vice President&Director of Technology Current

Organization Position Status
JIANGBO PHARMACEUTICALS, INC. Vice President&Director of Sales Current

Organization Position Status
JIANGBO PHARMACEUTICALS, INC. Vice President & Director, Equipment Current

Organization Position Status
JIANGBO PHARMACEUTICALS, INC. Outside Director Current
Talkingstocks.Com, LLC Director Current
JIANGBO PHARMACEUTICALS, INC. Board of Directors Current
Wharton Graduate School of the University of Pennsylvania MBA Former

Mr Arboleda has served as a director of the Registrant since November 30, 2006 and continue to serve as a director of the combined entity. Mr Arboleda has 40 years of experience in top executive positions in the private sector and is currently a partner in Miami-based Globis Group, LLC ("Globis"). Globis is a business development firm for the Ibero-American market, China and the United States. Among its current projects is securing a network of distributorships in Latin America for AMI-First Automotive Works, the largest vehicle manufacturer in China. In addition, Globis seeks opportunities for the Exxel Group, a large private equity fund based in Argentina. Prior to forming Globis, Mr Arboleda was the Executive VP of Ogden Corporation of NY, a Fortune 100 Service multinational corporation with worldwide interests in Aviation, Energy and Entertainment. Mr Arboleda was responsible for the Business Development efforts in Latin America and Spain for almost 10 years. He lead the efforts of opening 10 bases of airport services in Latin America and in Spain, of being awarded the largest airport management privatization project in the world, 33 airports in Argentina, in consortium with Malpensa 2000 of Milan, Italy, and a local Argentinean entrepreneur. He directed the construction of the largest Fair and Exhibit complex in Latin America, at La Rural de Palermo, in Buenos Aires, Argentina, a joint venture with the emblematic Sociedad Rural Argentina. Mr Arboleda holds a Bachelor of Architecture degree from MIT.

Organization Position Status
Globis LLC Founder Current
JIANGBO PHARMACEUTICALS, INC. Outside Director Current
JIANGBO PHARMACEUTICALS, INC. Board of Directors Former

Organization Position Status
JIANGBO PHARMACEUTICALS, INC. Financial Controller Current

Organization Position Status
JIANGBO PHARMACEUTICALS, INC. Board of Directors Current

Organization Position Status
JIANGBO PHARMACEUTICALS, INC. Director Current

Organization Position Status
JIANGBO PHARMACEUTICALS, INC. Director Current

Mr. Michael Marks, began serving as an independent Director on October 10, 2007. He is currently a managing director and principal of Sonnenblick Goldman Asia Pacific Limited, a firm that provides advisory services in real estate investments. Mr. Marks is also the President and Director of Middle Kingdom Alliance Corp., a special purpose acquisition corporation listed on Over-the-Counter Bulletin Board. Previously, Mr. Marks served as a director of Horwath Asia Pacific from January 2002 to December 2005 and was the Chief Executive Officer and Director at B2Gglobe (Pty) Limited from May 2001 to December 2002. Mr. Marks received both bachelor's and master's degrees in Commerce from the University of the Witwatersrand in Johannesburg, South Africa in 1994 and 1997, respectively, and also received a bachelor's degree in Psychology from the University of South Africa in 1998.

Organization Position Status
Middle Kingdom Alliance Corp. President Current
China Housing & Land Development, Inc. Board of Directors Current
JIANGBO PHARMACEUTICALS, INC. Board of Directors Current
Middle Kingdom Alliance Corp. Director Current
Land Development, Inc. Director Current
University of the Witwatersrand Master's Degrees In Commerce Former
University Corp. Bachelor's Degree In Psychology Former
University of the Witwatersrand Bachelor's Former

Organization Position Status
JIANGBO PHARMACEUTICALS, INC. Director Current

Organization Position Status
JIANGBO PHARMACEUTICALS, INC. Board of Directors Current

Executive News

  • Jiangbo Pharmaceuticals Reaffirms Guidance for Fiscal 2009

    Pharma Live - 9/08/09 - View Story

advertisement
JGBO $10.34 -0.06 (-0.58% )
Volume 9,212
Shares Outstanding 11.6M
Market Cap 119.9M
Year High 14.25
Year Low 3.40
Earnings Per Share 1.43
P/E Ratio 7.23
Dividend 0.00
Yield 0.00
advertisement
Click Here